Sponsored Links 
Zacks Investment Ideas feature highlights Ashford Hospitality Trust, Innospec and Stepan Co.
Print
Share
For Immediate Release
Chicago, IL – July 7, 2010 – Today, Zacks Investment Ideas feature highlights features Ashford Hospitality Trust (AHT - Snapshot Report), Innospec Inc. (IOSP - Snapshot Report) and Stepan Company (SCL - Snapshot Report).
3 Under-the-Radar Stocks
A good place to start is with Zacks Investment Research, which can help retail investors find undiscovered stocks. Using the Zacks Research Wizard, I screened for Zacks #1 Rank stocks with no analyst Buy ratings. That screen produced about 20 names. From there, I dug a little deeper to identify three names that should offer solid upside potential.
Here are three underfollowed and unloved stocks with a Zacks #1 Rank and no Buy ratings.
Ashford Hospitality Trust (AHT - Snapshot Report)
Ashford Hospitality Trust, a real estate investment trust (REIT), invests in the hospitality industry primarily in the U.S. The company invests in various segments and at various levels of the capital structure, including direct hotel investments, first mortgages, mezzanine loans, construction loans and sale-leaseback transactions.
For the first quarter, Ashford reported $0.32 per share, topping the Zacks Consensus by 8 cents, or 33.33%. In the last two quarters, Ashford has beaten the Zacks Consensus by an average of 21.8%.
In the last 60 days, the Zacks Consensus Estimate for 2010 is up 13 cents, or 12.8%, to $1.15, and the Zacks Consensus for 2011 is higher by 24 cents, or 18.2%, to $1.56.
Ashford is trading at 6x 2010 consensus EPS estimates and 4x 2011 consensus estimates.
Innospec Inc. (IOSP - Snapshot Report)
Innospec Inc. engages in the development, manufacture, blending and marketing of fuel additives and other specialty chemicals to oil refineries, and other chemical and industrial companies worldwide.
For the first quarter, Innospec earned $0.67 per share, matching the Zacks Consensus Estimate. In the last month, however, the Zacks Consensus Estimate for 2010 rose 55 cents, or 80.8% and the Zacks Consensus Estimate for 2011 increased 44 cents, or 44.0%.
Innospec shares trade at 8x 2010 consensus EPS estimates and 6x 2011 consensus EPS estimates.
Stepan Company (SCL - Snapshot Report)
Stepan Company engages in the production and sale of specialty and intermediate chemicals. The company operates in three segments: Surfactants, Polymers, and Specialty Products.
The company had first-quarter EPS of $1.76, easily beating the Zacks Consensus Estimate of $1.32. After its Q1 report, the Zacks Consensus Estimate for 2010 popped 42 cents, or 8.6%, to $5.28, and the Zacks Consensus Estimate for 2011 climbed $1.57, or 30.7%, to $6.69.
Stepan shares trade at 12x 2010 consensus EPS estimates and 10x 2011 consensus EPS estimates.
Here are three underfollowed and unloved stocks with a Zacks #1 Rank and no Buy ratings.
Ashford Hospitality Trust (AHT - Snapshot Report)
Ashford Hospitality Trust, a real estate investment trust (REIT), invests in the hospitality industry primarily in the U.S. The company invests in various segments and at various levels of the capital structure, including direct hotel investments, first mortgages, mezzanine loans, construction loans and sale-leaseback transactions.
For the first quarter, Ashford reported $0.32 per share, topping the Zacks Consensus by 8 cents, or 33.33%. In the last two quarters, Ashford has beaten the Zacks Consensus by an average of 21.8%.
In the last 60 days, the Zacks Consensus Estimate for 2010 is up 13 cents, or 12.8%, to $1.15, and the Zacks Consensus for 2011 is higher by 24 cents, or 18.2%, to $1.56.
Ashford is trading at 6x 2010 consensus EPS estimates and 4x 2011 consensus estimates.
Innospec Inc. (IOSP - Snapshot Report)
Innospec Inc. engages in the development, manufacture, blending and marketing of fuel additives and other specialty chemicals to oil refineries, and other chemical and industrial companies worldwide.
For the first quarter, Innospec earned $0.67 per share, matching the Zacks Consensus Estimate. In the last month, however, the Zacks Consensus Estimate for 2010 rose 55 cents, or 80.8% and the Zacks Consensus Estimate for 2011 increased 44 cents, or 44.0%.
Innospec shares trade at 8x 2010 consensus EPS estimates and 6x 2011 consensus EPS estimates.
Stepan Company (SCL - Snapshot Report)
Stepan Company engages in the production and sale of specialty and intermediate chemicals. The company operates in three segments: Surfactants, Polymers, and Specialty Products.
The company had first-quarter EPS of $1.76, easily beating the Zacks Consensus Estimate of $1.32. After its Q1 report, the Zacks Consensus Estimate for 2010 popped 42 cents, or 8.6%, to $5.28, and the Zacks Consensus Estimate for 2011 climbed $1.57, or 30.7%, to $6.69.
Stepan shares trade at 12x 2010 consensus EPS estimates and 10x 2011 consensus EPS estimates.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms. It monitors more than 200,000 earnings estimates, looking for changes.
Then when changes are discovered, they’re applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock picking system; the Zacks Rank, continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter Profit from the Pros. In short, it’s your steady flow of profitable ideas GUARANTEED to be worth your time. Get your free subscription to Profit from the Pros at: http://at.zacks.com/?id=7299
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contact: Mark Vickery
Associate Editor
Company: Zacks.com
Phone: 312-265-9380
Phone: 312-265-9380
Email: markv@zacks.com
Visit: www.zacks.com
Read the full analyst report on AHT
Read the full analyst report on IOSP
Read the full analyst report on SCL
Loading Stories...
-74.92